View in EDS HTML Full Text PDF Full Text

Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.
Authors: Hosseini K; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran., Soleimani H; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran. hamid.r.soleimani90@gmail.com.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran. hamid.r.soleimani90@gmail.com.; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713139, Iran. hamid.r.soleimani90@gmail.com., Maleki S; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; School of Medicine, Guilan University of Medical Sciences (GUMS), Rasht, Guilan Province, Iran., Nasrollahizadeh A; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran., Tayebi S; Centre for Clinical Research Sormland, Uppsala University, Uppsala, SE, Sweden., Nelson J; California Cardiovascular Institute, Fresno, CA, USA., Heffron SP; Center for the Prevention of Cardiovascular Disease, Leon H. Charney Division of Cardiology, NYU Langone Health, New York University Grossman School of Medicine, New York, NY, USA.
Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2024 Jul 30; Vol. 24 (1), pp. 395. Date of Electronic Publication: 2024 Jul 30.
Publication Type: Systematic Review; Meta-Analysis; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261 (Electronic) Linking ISSN: 14712261 NLM ISO Abbreviation: BMC Cardiovasc Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39080549
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hosseini+K%22">Hosseini K</searchLink>; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.<br /><searchLink fieldCode="AU" term="%22Soleimani+H%22">Soleimani H</searchLink>; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran. hamid.r.soleimani90@gmail.com.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran. hamid.r.soleimani90@gmail.com.; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713139, Iran. hamid.r.soleimani90@gmail.com.<br /><searchLink fieldCode="AU" term="%22Maleki+S%22">Maleki S</searchLink>; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; School of Medicine, Guilan University of Medical Sciences (GUMS), Rasht, Guilan Province, Iran.<br /><searchLink fieldCode="AU" term="%22Nasrollahizadeh+A%22">Nasrollahizadeh A</searchLink>; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.<br /><searchLink fieldCode="AU" term="%22Tayebi+S%22">Tayebi S</searchLink>; Centre for Clinical Research Sormland, Uppsala University, Uppsala, SE, Sweden.<br /><searchLink fieldCode="AU" term="%22Nelson+J%22">Nelson J</searchLink>; California Cardiovascular Institute, Fresno, CA, USA.<br /><searchLink fieldCode="AU" term="%22Heffron+SP%22">Heffron SP</searchLink>; Center for the Prevention of Cardiovascular Disease, Leon H. Charney Division of Cardiology, NYU Langone Health, New York University Grossman School of Medicine, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100968539%22">BMC cardiovascular disorders</searchLink> [BMC Cardiovasc Disord] 2024 Jul 30; Vol. 24 (1), pp. 395. <i>Date of Electronic Publication: </i>2024 Jul 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Systematic Review; Meta-Analysis; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968539 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712261%22">14712261 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cardiovasc Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39080549
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12872-024-04057-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 395
    Titles:
      – TitleFull: Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hosseini K
      – PersonEntity:
          Name:
            NameFull: Soleimani H
      – PersonEntity:
          Name:
            NameFull: Maleki S
      – PersonEntity:
          Name:
            NameFull: Nasrollahizadeh A
      – PersonEntity:
          Name:
            NameFull: Tayebi S
      – PersonEntity:
          Name:
            NameFull: Nelson J
      – PersonEntity:
          Name:
            NameFull: Heffron SP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 07
              Text: 2024 Jul 30
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2261
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cardiovascular disorders
              Type: main
ResultId 1